Sharon Osbourne Warns of Rapid Weight Loss with Semaglutide, Saying She’s Now Under 100 Pounds
Sharon Osbourne is cautioning people to “be careful what you wish for” as she reveals she now weighs less than 100 pounds from weight loss resulting from the use of semaglutide, a medication she started taking under the brand name Ozempic last December. Although the medication is FDA-approved for type 2 diabetes, it is used off-label for weight loss.
In an interview with the Daily Mail, the 71-year-old shared her experience with the medication, expressing concerns about the drastic change she’s seen in her body and the dangers of addiction to weight loss. She stated, “I’ve been off it for a while now, but my warning is don’t give it to teenagers, it’s just too easy. You can lose so much weight and it’s easy to become addicted to that, which is very dangerous. I couldn’t stop losing weight and now I’ve lost 42 pounds and I can’t afford to lose any more.”
Osbourne also commented on her appearance, saying she feels she’s become too skinny and gaunt. She emphasized, “I know I look gaunt … I’m too gaunt and I can’t put any weight on. I want to, because I feel I’m too skinny. I’m under 100 pounds and I don’t want to be.”
This isn’t the first time a public figure has expressed reservations about their experience using the injectable medication. Golnesa “GG” Gharachedaghi from the reality show Shahs of Sunset shared on Instagram that she was “cutting down” on her dosage after losing more weight than anticipated. She has since started a lower dose of the medication that prioritizes weight maintenance instead of continued weight loss.
Dr. Priya Jaisinghani, a clinical assistant professor at NYU Grossman School of Medicine specializing in obesity medicine, emphasizes the importance of determining a “safe rate of weight loss” with a healthcare provider for any sort of weight management. She also discusses the potential health implications of rapid weight loss, highlighting the need for lifestyle changes in conjunction with medication.
Despite the stigma surrounding the off-label use of the medication, Osbourne has been open about her experience, stating, “I try to be as truthful about myself as possible. I am what I am,” in the interview with the Daily Mail.
While the conversation around semaglutide and its off-label use continues, it’s important for individuals to consider the implications and risks associated with rapid weight loss.
